tiprankstipranks
Monogram Orthopaedics Inc (MGRM)
NASDAQ:MGRM
US Market

Monogram Orthopaedics Inc (MGRM) Stock Price & Analysis

42 Followers

MGRM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.53 - $6.55
Previous Close$2.25
Volume64.40K
Average Volume (3M)242.35K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$10.08M
Total Debt (Recent Filing)$461.64K
Price to Earnings (P/E)
Beta1.71
Mar 14, 2025
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.53
Shares Outstanding31,670,375
10 Day Avg. Volume55,696
30 Day Avg. Volume242,347
Standard Deviation0.18
R-Squared0.29
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)7.32
Price to Sales (P/S)195.23
Price to Cash Flow (P/CF)-4.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

0.00%0.06%1.14%98.80%
0.00%
Insiders
1.14% Other Institutional Investors
98.80% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services

MGRM FAQ

What was Monogram Orthopaedics Inc’s price range in the past 12 months?
Monogram Orthopaedics Inc lowest stock price was $1.53 and its highest was $6.55 in the past 12 months.
    What is Monogram Orthopaedics Inc’s market cap?
    Currently, no data Available
    When is Monogram Orthopaedics Inc’s upcoming earnings report date?
    Monogram Orthopaedics Inc’s upcoming earnings report date is Mar 14, 2025 which is in 277 days.
      How were Monogram Orthopaedics Inc’s earnings last quarter?
      Monogram Orthopaedics Inc released its earnings results on May 14, 2024. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.12 by $0.01.
        Is Monogram Orthopaedics Inc overvalued?
        According to Wall Street analysts Monogram Orthopaedics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Monogram Orthopaedics Inc pay dividends?
          Monogram Orthopaedics Inc does not currently pay dividends.
          What is Monogram Orthopaedics Inc’s EPS estimate?
          Monogram Orthopaedics Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Monogram Orthopaedics Inc have?
          Monogram Orthopaedics Inc has 31,670,376 shares outstanding.
            What happened to Monogram Orthopaedics Inc’s price movement after its last earnings report?
            Monogram Orthopaedics Inc reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.12. Following the earnings report the stock price went up 6.842%.
              Which hedge fund is a major shareholder of Monogram Orthopaedics Inc?
              Currently, no hedge funds are holding shares in MGRM
              ---

              Monogram Orthopaedics Inc Stock Smart Score

              Company Description

              Monogram Orthopaedics Inc

              Monogram Orthopedics takes immense pride in our unwavering commitment to Personalized Orthopedic Care and our relentless pursuit to Revolutionize Orthopedic Joint Replacement. Today, we stand as a symbol of hard work and determination in the field of orthopedic healthcare.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Conmed
              Orthofix
              Orasure Technologies
              Smith & Nephew Snats
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis